Northern Trust Corp Biocept Inc Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.88 - $2.27 $506 - $1,305	-575 Reduced 2.1%	26,818 $25,000
Q1 2022 May 13, 2022	BUY	$1.83 - $3.97 $137 - $297	75 Added 0.27%	27,393 $63,000
Q3 2021 Nov 15, 2021	SELL	$3.39 - $4.34 $2,471 - $3,163	-729 Reduced 2.6%	27,318 $110,000
Q1 2021 May 12, 2021	BUY	$4.74 - $7.94 $7,527 - $12,608	1,588 Added 6.0%	28,047 $143,000
Q4 2020 Feb 11, 2021	SELL	$4.31 - $6.16 $5,189 - $7,416	-1,204 Reduced 4.35%	26,459 $117,000
Q3 2020 Nov 16, 2020	BUY	$3.61 - $11.4 $99,863 - $315,358	27,663 New	27,663 $122,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.